Rekvina Laboratories Limited (BOM:526075)

Rekvina Laboratories Balance Sheet

Financials in millions INR. Fiscal year is April - March.

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Cash & Equivalents	0.15	0.25	0.1	0.1	0
Cash & Short-Term Investments	0.15	0.25	0.1	0.1	0
Cash Growth	-39.04%	164.21%	-3.06%	2563.04%	-82.48%
Accounts Receivable	5.97	-	-	-	-
Receivables	5.97	-	-	-	-
Other Current Assets	5.77	0.07	-	-	-
Total Current Assets	11.89	0.33	0.1	0.1	0
Property, Plant & Equipment	-	-	-	1.46	1.46
Long-Term Investments	-	-	-	0.46	0.46
Total Assets	11.89	0.33	0.1	2.02	1.92
Accounts Payable	3.94	1.07	1.14	1.06	1.76
Accrued Expenses	-	0.11	0.01	0.02	0.03
Short-Term Debt	14.73	2.47	0.4	0.81	-
Other Current Liabilities	5.5	-	0.5	0	-
Total Current Liabilities	24.17	3.65	2.05	1.89	1.78
Total Liabilities	24.17	3.65	2.05	1.89	1.78
Common Stock	30.14	30.14	30.14	30.14	30.14
Retained Earnings	-	-33.46	-32.09	-30.01	-30
Comprehensive Income & Other	-42.42	-	-	-	-
Shareholders' Equity	-12.28	-3.32	-1.95	0.13	0.14
Total Liabilities & Equity	11.89	0.33	0.1	2.02	1.92
Total Debt	14.73	2.47	0.4	0.81	-
Net Cash (Debt)	-14.57	-2.22	-0.3	-0.72	0
Net Cash Growth	-	-	-	-	-82.48%
Net Cash Per Share	-2.40	-0.37	-0.05	-0.12	0.00
Filing Date Shares Outstanding	6.05	6.03	6.03	6.03	6.07
Total Common Shares Outstanding	6.05	6.03	6.03	6.03	6.07
Working Capital	-12.28	-3.32	-1.95	-1.79	-1.78
Book Value Per Share	-2.03	-0.55	-0.32	0.02	0.02
Tangible Book Value	-12.28	-3.32	-1.95	0.13	0.14
Tangible Book Value Per Share	-2.03	-0.55	-0.32	0.02	0.02
Land	-	-	-	0.17	0.17
Buildings	-	-	-	2.03	2.02
Machinery	-	-	-	2.9	2.9

Source: S&P Global Market Intelligence. Standard template. Financial Sources.